OpenAlex
PricingAboutJobs
Log inGet started
Work

A Phase I/pilot study of sequential doxorubicin/vinorelbine: effects on p53 and microtubule-associated protein 4.

PubMed

Year: 2002
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Judy Bash-Babula, Deborah Toppmeyer, Marie Labassi, Janice Reidy, Michelle Orlick, Rachelle Senzon, Elizabeth Alli, Thomas Kearney, David August, Weichung Shih, Jin-Ming Yang, William N Hait
Institutions: University of Medicine and Dentistry of New Jersey, Rutgers Cancer Institute, Rutgers, The State University of New Jersey
Language: English

Topic: Cancer-related Molecular Pathways
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: doxorubicin, vinorelbine, p53, MAP4, breast cancer, sequential chemotherapy, vinca alkaloids, DNA-damaging agents, chemosensitivity, peripheral blood mononuclear cells, tumor tissue, treatment safety, drug response biomarkers
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Awards: SEQUENTIAL DOXORUBICIN AND VINORELBINE IN BREAST CANCER, MOLECULAR DETERMINANTS OF DRUG SENSITIVITY, Cancer Center Support Grant
OpenAlex ID: W2245308448
FWCI: 1.188
Cites: 41
Cited by: 30
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms